2,2',2''-trichlorotriethylamine has been researched along with Neoplasms in 4 studies
2,2',2''-trichlorotriethylamine: RN given refers to parent cpd; structure
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| STRELEC, J | 1 |
| Goodman, LS | 1 |
| Wintrobe, MM | 1 |
| Dameshek, W | 1 |
| Goodman, MJ | 1 |
| Gilman, A | 1 |
| McLennan, MT | 1 |
| Ujházy, V | 1 |
| Siracký, J | 1 |
2 reviews available for 2,2',2''-trichlorotriethylamine and Neoplasms
| Article | Year |
|---|---|
Heterogeneity of tumor cells.
Topics: Antineoplastic Agents; Cell Separation; Cells, Cultured; DNA, Neoplasm; Neoplasms; Nitrogen Mustard | 1980 |
Trichlorotriethylamine hydrochloride.
Topics: Adenocarcinoma; Animals; Carcinogens; Carcinoma 256, Walker; Chromosome Aberrations; Drug Evaluation | 1975 |
2 other studies available for 2,2',2''-trichlorotriethylamine and Neoplasms
| Article | Year |
|---|---|
[Treatment of bone cancer with preparation TS 160].
Topics: Bone Neoplasms; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds | 1951 |
Landmark article Sept. 21, 1946: Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders.
Topics: History, 20th Century; Hodgkin Disease; Humans; Leukemia; Lymphoma, Non-Hodgkin; Mechlorethamine; Ne | 1984 |